Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Lambertini

Showing results (1-10 of 375) with videos related to

Pageof 38
Sort By:
ESMO Open|May 8, 2020
<i>ESMO Open</i> special series on new emerging targets in cancer immunotherapyMatteo Lambertini
ESMO Open|May 15, 2020
ESMO Open: news in breast cancer 2019Matteo Lambertini
Recenti Progressi in Medicina|December 17, 2024
[Sacituzumab govitecan in the treatment of triple-negative metastatic breast cancer.]Marta Perachino, Matteo Lambertini
Nature Reviews. Clinical Oncology|July 6, 2023
Safety of interrupting adjuvant endocrine therapy to conceive: early data are POSITIVELuca Arecco, Matteo Lambertini
Oncotarget|February 21, 2019
Pregnancies in young women with diagnosis and treatment of HER2-positive breast cancerMatteo Lambertini, Giulia Viglietti
Recenti Progressi in Medicina|November 17, 2024
Marta Perachino, Matteo Lambertini
The Lancet. Oncology|September 18, 2018
Another step towards improving oncofertility counselling of young women with Hodgkin's lymphomaMatteo Lambertini, Isabelle Demeestere
The Oncologist|February 25, 2020
It Is Time to Talk About Fertility and ImmunotherapyNarjust Duma, Matteo Lambertini
Recenti Progressi in Medicina|October 24, 2024
Marta Perachino, Matteo Lambertini
Recenti Progressi in Medicina|June 10, 2024
Marta Perachino, Matteo Lambertini
Pageof 38

Showing results (1-10 of 375) with videos related to

Sort By:
Pageof 38
ESMO Open|May 8, 2020
<i>ESMO Open</i> special series on new emerging targets in cancer immunotherapyMatteo Lambertini
ESMO Open|May 15, 2020
ESMO Open: news in breast cancer 2019Matteo Lambertini
Recenti Progressi in Medicina|December 17, 2024
[Sacituzumab govitecan in the treatment of triple-negative metastatic breast cancer.]Marta Perachino, Matteo Lambertini
Nature Reviews. Clinical Oncology|July 6, 2023
Safety of interrupting adjuvant endocrine therapy to conceive: early data are POSITIVELuca Arecco, Matteo Lambertini
Oncotarget|February 21, 2019
Pregnancies in young women with diagnosis and treatment of HER2-positive breast cancerMatteo Lambertini, Giulia Viglietti
Recenti Progressi in Medicina|November 17, 2024
Marta Perachino, Matteo Lambertini
The Lancet. Oncology|September 18, 2018
Another step towards improving oncofertility counselling of young women with Hodgkin's lymphomaMatteo Lambertini, Isabelle Demeestere
The Oncologist|February 25, 2020
It Is Time to Talk About Fertility and ImmunotherapyNarjust Duma, Matteo Lambertini
Recenti Progressi in Medicina|October 24, 2024
Marta Perachino, Matteo Lambertini
Recenti Progressi in Medicina|June 10, 2024
Marta Perachino, Matteo Lambertini
Pageof 38